275 related articles for article (PubMed ID: 28796092)
1. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
[TBL] [Abstract][Full Text] [Related]
2. SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours.
Petremann M; Romanet C; Broussy A; Van Ba CT; Poli S; Dyhrfjeld-Johnsen J
Otol Neurotol; 2019 Feb; 40(2):254-263. PubMed ID: 30570608
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant treatment reduces blast-induced cochlear damage and hearing loss.
Ewert DL; Lu J; Li W; Du X; Floyd R; Kopke R
Hear Res; 2012 Mar; 285(1-2):29-39. PubMed ID: 22326291
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A
Audiology; 2001; 40(5):253-64. PubMed ID: 11688544
[TBL] [Abstract][Full Text] [Related]
5. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate.
Choe WT; Chinosornvatana N; Chang KW
Otol Neurotol; 2004 Nov; 25(6):910-5. PubMed ID: 15547419
[TBL] [Abstract][Full Text] [Related]
6. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
Bielefeld EC
Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
[TBL] [Abstract][Full Text] [Related]
7. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA
Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
[TBL] [Abstract][Full Text] [Related]
10. Distortion-product otoacoustic emissions and auditory brainstem responses sensitivity assessment in cisplatin-induced ototoxicity in rats.
Freitas MR; Silva VC; Brito GA; Carvalho Junior JV; Gomes Junior RM; Ribeiro Rde A
Braz J Otorhinolaryngol; 2009; 75(4):476-84. PubMed ID: 19784413
[TBL] [Abstract][Full Text] [Related]
11. Noise-induced threshold shift dynamics measured with distortion-product otoacoustic emissions and auditory evoked potentials in chinchillas with inner hair cell deficient cochleas.
Hamernik RP; Ahroon WA; Jock BM; Bennett JA
Hear Res; 1998 Apr; 118(1-2):73-82. PubMed ID: 9606062
[TBL] [Abstract][Full Text] [Related]
12. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.
Fernandez K; Wafa T; Fitzgerald TS; Cunningham LL
Hear Res; 2019 Apr; 375():66-74. PubMed ID: 30827780
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
15. Effects of ozone (O
Koçak HE; Taşkın Ü; Aydın S; Oktay MF; Altınay S; Çelik DS; Yücebaş K; Altaş B
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4153-4159. PubMed ID: 27221387
[TBL] [Abstract][Full Text] [Related]
16. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
Fang B; Xiao H
Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670
[TBL] [Abstract][Full Text] [Related]
18. Light microscopy study of cisplatin-induced ototoxicity in rats.
de Freitas MR; de Castro Brito GA; de Carvalho JV; Gomes RM; Barreto Martins MJ; de Albuquerque Ribeiro R
J Laryngol Otol; 2009 Jun; 123(6):590-7. PubMed ID: 19144244
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model.
Salehi P; Akinpelu OV; Waissbluth S; Peleva E; Meehan B; Rak J; Daniel SJ
Otol Neurotol; 2014 Aug; 35(7):1131-9. PubMed ID: 24841915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
